Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.

Pathology - 1 Jan 2009

Karlou Maria, Saetta Angelica A, Korkolopoulou Penelope, Levidou Georgia, Papanastasiou Pollyanthi, Boltetsou Evmorfia, Isaiadis Dimitrios, Pavlopoulos Petros, Thymara Irene, Thomas-Tsagli Euphemia, Patsouris Efstratios

Abstract excerpt

AIM: The analysis of the presence of B-Raf gene mutations in relation to ERK1/2 activation in bladder urothelial carcinoma (UC), in order to determine their potential role in tumour aggressiveness and patients' survival. METHODS: Polymerase chain reaction-single strand confirmation polymorphism (...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Enzyme Activation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Mitogen-Activated Protein Kinase 1

Share to Mitogen-Activated Protein Kinase 3

Share to Polymorphism, Single-Stranded Conformational

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 19404844
DOI: 10.1080/00313020902885011

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19404844-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.PMID 19404844Read ↗

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.Semantic proximity Read ↗

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.Semantic proximity Read ↗

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contextsSemantic proximity Read ↗

A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.Semantic proximity Read ↗

No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.Semantic proximity Read ↗

Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.Semantic proximity Read ↗

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.Semantic proximity Read ↗

HER2 as a target in invasive urothelial carcinoma.Semantic proximity Read ↗

Oncogenic Activation of Fibroblast Growth Factor Receptor-3 and RAS Genes as Non-Overlapping Mutual Exclusive Events in Urinary Bladder Cancer.Semantic proximity Read ↗

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.Semantic proximity Read ↗

Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization.Semantic proximity Read ↗

Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.